developing < development < developmental

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 87.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000086 (1999)	Hunein F. Maassab [États-Unis] ; Martin L. Bryant [États-Unis]	The development of live attenuated cold‐adapted influenza virus vaccine for humans
000130 (1999)	H. F. Maassab [États-Unis]	Principle of cold-adaptation in the derivation of live attenuated respiratory virus vaccines
000209 (2006)	Dany Shoham [Israël]	Review: Molecular evolution and the feasibility of an avian influenza virus becoming a pandemic strain––a conceptual shift
000251 (2007)	Jindrich Cinatl Jr [Allemagne] ; Martin Michaelis [Allemagne] ; Hans W. Doerr [Allemagne]	The threat of avian influenza A (H5N1). Part IV: development of vaccines
000276 (2009)	Martin Michaelis [Allemagne] ; Hans Wilhem Doerr [Allemagne] ; Jindrich Cinatl Jr. [Allemagne]	Novel swine-origin influenza A virus in humans: another pandemic knocking at the door
000284 (1996)	Guangxiang Luo ; Richard Colonno ; Mark Krystal	Characterization of a Hemagglutinin-Specific Inhibitor of Influenza A Virus
000352 (1977)	Koichiro Maeno [Japon] ; Saiji Yoshii ; Tetsuya Yoshida ; Masao Iinuma ; Yasuko Kawamoto ; Toshisada Matsumoto	Intracellular Development of Membrane Protein of Influenza Virus
000370 (2003)	Susan J. Baigent [Royaume-Uni] ; John W. Mccauley [Royaume-Uni]	Influenza type A in humans, mammals and birds: Determinants of virus virulence, host‐range and interspecies transmission
000405 (1975)	Brian R. Murphy [États-Unis] ; Susan B. Spring [États-Unis] ; Douglas D. Richman [États-Unis] ; Eveline L. Tierney [États-Unis] ; Julius Kasel [États-Unis] ; Robert M. Chanock [États-Unis]	Temperature-sensitive mutants of influenza virus
000490 (1976)	Brian R. Murphy ; Douglas D. Richman ; Susan B. Spring ; Robert M. Chanock	Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children
000539 (1998)	A. A. Popov	Methods of solving certain two-dimensional problems of doppler tomography
000584 (2000)	K. Subbarao [États-Unis] ; J. Katz [États-Unis]	Avian influenza viruses infecting humans
000607 (1998)	C. Scholtissek [États-Unis] ; G. Quack [Allemagne] ; H. D Klenk [Allemagne] ; R. G Webster [États-Unis]	How to overcome resistance of influenza A viruses against adamantane derivatives
000618 (2007)	William B. Ershler [États-Unis] ; Stefan Gravenstein [États-Unis] ; Zeba S. Geloo [États-Unis]	Thymosin Alpha 1 as an Adjunct to Influenza Vaccination in the Elderly
000688 (2000)	J. Yoshimoto [Japon] ; S. Yagi [Japon] ; J. Ono [Japon] ; K. Sugita [Japon] ; N. Hattori [Japon] ; T. Fujioka [Japon] ; T. Fujiwara [Japon] ; H. Sugimoto [Japon] ; N. Hashimoto [Japon]	Development of Anti‐influenza Drugs: II. Improvement of Oral and Intranasal Absorption and the Anti‐influenza Activity of Stachyflin Derivatives
000691 (2012)	E. V. Kostina [Russie] ; V. A. Ryabinin [Russie] ; G. A. Maksakova [Russie] ; A. N. Sinyakov [Russie]	A second generation universal microarray for subtyping influenza a virus
000692 (2010)	Chad M. Fuller [Royaume-Uni] ; Lina Brodd [Royaume-Uni] ; Richard M. Irvine [Royaume-Uni] ; Dennis J. Alexander [Royaume-Uni] ; Elizabeth W. Aldous [Royaume-Uni]	Development of an L gene real-time reverse-transcription PCR assay for the detection of avian paramyxovirus type 1 RNA in clinical samples
000714 (2001)	Suzanne L. Epstein [États-Unis] ; Abigail Stack [États-Unis] ; Julia A. Misplon [États-Unis] ; Chia-Yun Lo [États-Unis] ; Howard Mostowski [États-Unis] ; Jack Bennink [États-Unis] ; Kimberly A. Benton [États-Unis] ; Lynn Cooper [États-Unis] ; Athene Hodges [États-Unis] ; Kanta Subbarao [États-Unis]	Vaccination with DNA encoding conserved influenza viral proteins
000728 (2001)	A. Horváth [Hongrie] ; I. Andersen [Danemark] ; K. Junker [Danemark] ; B. Lyck Fogh-Schultz [Danemark] ; E. Holm Nielsen [Danemark] ; S. Gizurarson [Islande] ; O. Andersen [Danemark] ; J. Kármán [Hongrie] ; E. Rajnavölgyi [Hongrie] ; A. Erdei [Hongrie] ; S.-E Svehag [Danemark]	Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies
000729 (2000)	T. G. Boyce [États-Unis] ; G. A. Poland [États-Unis]	Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review
000752 (1988)	Robert M. Chanock [États-Unis] ; Brian R. Murphy [États-Unis] ; Peter L. Collins [États-Unis] ; Kathleen V. W. Coelingh [États-Unis] ; Robert A. Olmsted [États-Unis] ; Mark H. Snyder [États-Unis] ; Melanie K. Spriggs [États-Unis] ; Gregory A. Prince [États-Unis] ; Bernard Moss [États-Unis] ; Jorge Flores [États-Unis] ; Mario Gorziglia [États-Unis] ; Albert Z. Kapikian [États-Unis]	Live viral vaccines for respiratory and enteric tract diseases

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "development" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "development" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    development
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021